Puma Biotechnology Q1 Earnings Call Highlights
PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised
Puma Biotechnology, Inc. (PBYI) Q1 2026 Earnings Call Transcript
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
Puma Biotechnology Reports First Quarter 2026 Financial Results
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Gun Makers Reach Cooperation Pact After Months of Tense Proxy Battle
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above 200 Day Moving Average – Should You Sell?
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates
Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above 200-Day Moving Average – What’s Next?
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
Puma Biotechnology (NASDAQ:PBYI) Stock Price Crosses Above 200-Day Moving Average – Here’s What Happened
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy?
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
Puma Biotechnology: Step By Step In Making A Transition
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (PBYI) Q3 2025 Earnings Call Transcript
PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised
Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates
Puma Biotechnology Reports Third Quarter 2025 Financial Results
15,168 Shares in Puma Biotechnology, Inc. $PBYI Bought by Ethic Inc.
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
3 High-Flying Stocks Under $10 to Buy Hand Over Fist Right Now
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues
Puma (PBYI) Q2 Revenue Rises 11%
Puma Biotechnology, Inc. (PBYI) Q2 2025 Earnings Call Transcript
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates
Puma Biotechnology Reports Second Quarter Financial Results
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results